S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
OTCMKTS:CANN

General Cannabis Stock Forecast, Price & News

$0.62
+0.02 (+3.11 %)
(As of 01/15/2021 08:27 PM ET)
Add
Compare
Today's Range
$0.59
Now: $0.62
$0.63
50-Day Range
$0.44
MA: $0.55
$0.71
52-Week Range
$0.26
Now: $0.62
$0.72
Volume705,600 shs
Average Volume427,600 shs
Market Capitalization$37.56 million
P/E RatioN/A
Dividend YieldN/A
Beta0.95
General Cannabis Corp provides products and services to the regulated cannabis industry and non-cannabis customers in the United States. The company operates in two segments, Operations Consulting and Products; and Capital Investments and Real Estate.The Operations Consulting and Products segment provides consulting services to the cannabis industry comprising obtaining licenses, compliance, cultivation, retail operations, logistical support, facility design and construction, and expansion of existing operations. The Capital Investments and Real Estate segment provides loans or revolving lines of credit; leases real estate properties; and invests in businesses. The company was formerly known as Advanced Cannabis Solutions, Inc. and changed its name to General Cannabis Corp in June 2015. General Cannabis Corp was incorporated in 2013 and is based in Denver, Colorado.

MarketRank

Overall MarketRank

0.61 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Detective & armored car services
Sub-IndustryCannabis
Current SymbolOTCMKTS:CANN
Previous SymbolNASDAQ:CANN
CUSIPN/A
CIKN/A
Phone303-759-1300
Employees76

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.67 million
Book Value($0.15) per share

Profitability

Net Income$-15,480,000.00
Net Margins-167.65%

Miscellaneous

Market Cap$37.56 million
Next Earnings Date5/13/2021 (Estimated)
OptionableNot Optionable
$0.62
+0.02 (+3.11 %)
(As of 01/15/2021 08:27 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CANN News and Ratings via Email

Sign-up to receive the latest news and ratings for CANN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











General Cannabis (OTCMKTS:CANN) Frequently Asked Questions

How has General Cannabis' stock price been impacted by COVID-19 (Coronavirus)?

General Cannabis' stock was trading at $0.4550 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CANN stock has increased by 35.7% and is now trading at $0.6176.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than General Cannabis?

Wall Street analysts have given General Cannabis a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but General Cannabis wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is General Cannabis' next earnings date?

General Cannabis is scheduled to release its next quarterly earnings announcement on Thursday, May 13th 2021.
View our earnings forecast for General Cannabis
.

How were General Cannabis' earnings last quarter?

General Cannabis Corp (OTCMKTS:CANN) released its quarterly earnings results on Thursday, November, 12th. The company reported ($0.01) EPS for the quarter. The business earned $1.59 million during the quarter.
View General Cannabis' earnings history
.

Who are some of General Cannabis' key competitors?

What other stocks do shareholders of General Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other General Cannabis investors own include (CGC), Terra Tech (TRTC), Aurora Cannabis (ACBFF), Cronos Group (CRON), GW Pharmaceuticals (GWPH), 22nd Century Group (XXII), Zynerba Pharmaceuticals (ZYNE), Cannabis Sativa (CBDS), Aurora Cannabis (ACB) and Alibaba Group (BABA).

Who are General Cannabis' key executives?

General Cannabis' management team includes the following people:
  • Mr. Steven D. Gutterman, CEO & Director (Age 51, Pay $346.7k)
  • Mr. Brian Andrews, Advisor (Age 58, Pay $222.76k)
  • Ms. Jessica Bast, Controller (Age 43, Pay $134.22k)
  • Ms. Diane Jones, CFO, Principal Financial & Accounting Officer (Age 57)
  • Mr. Richard Cardinal, VP of Operations
  • Mr. Bryan DeHaven, Managing Director of Chiefton Supply Co
  • Mr. David Hirst, Managing Director of Chiefton Supply

What is General Cannabis' stock symbol?

General Cannabis trades on the OTCMKTS under the ticker symbol "CANN."

How do I buy shares of General Cannabis?

Shares of CANN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is General Cannabis' stock price today?

One share of CANN stock can currently be purchased for approximately $0.62.

How big of a company is General Cannabis?

General Cannabis has a market capitalization of $37.56 million and generates $3.67 million in revenue each year. General Cannabis employs 76 workers across the globe.

What is General Cannabis' official website?

The official website for General Cannabis is www.generalcann.com.

How can I contact General Cannabis?

General Cannabis' mailing address is 6565 EAST EVANS AVENUE, DENVER CO, 80224. The company can be reached via phone at 303-759-1300.

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.